Specifically, we found high TMB correlated significantly with mutations in TP53, KEAP1, and SMARCA4, which have been shown to promote aggressive tumor behavior, and immunosuppressive tumor microenvironments (36–39). Here, KEAP1 is linked to neoplasm.